You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Colorcon
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Nephron Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NEPHRON, and what generic and branded alternatives to NEPHRON drugs are available?

NEPHRON has nine approved drugs.



Summary for Nephron
US Patents:0
Tradenames:6
Ingredients:6
NDAs:9

Drugs and US Patents for Nephron

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nephron BUDESONIDE budesonide SUSPENSION;INHALATION 078202-001 Mar 30, 2009 AN RX No No   Start Trial   Start Trial
Nephron BETA-2 isoetharine hydrochloride SOLUTION;INHALATION 086711-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Nephron METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 071726-001 Jul 14, 1988 DISCN No No   Start Trial   Start Trial
Nephron ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 076355-001 Jun 28, 2004 AN RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Merck
Boehringer Ingelheim
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.